Dubai Headquartered · Global Operations · Est. CSP Holdings International
The World's Sovereign

Health Supply Operating System.

22 active markets. 300+ manufacturing relationships. A single sovereign platform that delivers the highest clinical standards — directly from issuing authority — to every health system we serve. In real time. At scale. Saving lives.

22
Active Operating Markets
300+
Health Manufacturing Relationships
93
AI Clinical Match Accuracy
Zero
Intermediaries in Supply Chain
22 Active Markets 300+ Manufacturing Relationships Single Entry · Mass Exposure Direct from Issuing Authority Sovereign Platform Real-Time Responsiveness Principal Buyer · Zero Intermediaries Clinical Grade · Institutional Scale Dubai HQ · Africa · Middle East 22 Active Markets 300+ Manufacturing Relationships Single Entry · Mass Exposure Direct from Issuing Authority Sovereign Platform Real-Time Responsiveness Principal Buyer · Zero Intermediaries Clinical Grade · Institutional Scale Dubai HQ · Africa · Middle East
01
Who We Are

Principal
Buyer.
Not a
Distributor.

CSP Holdings International is a Dubai-headquartered independent market developer operating as principal buyer across Africa and the Middle East. We hold direct commercial relationships with over 300 health manufacturers — making us the most connected single point of entry into health supply markets in the regions we serve.

We are not a distributor, not an agent, and not a broker. Every product we supply carries full manufacturer authority, clinical traceability, and regulatory integrity — direct from source to point of care.

🏛
Principal Buyer Status
Direct approved commercial relationships with 300+ manufacturers. No third-party intermediaries. No grey market exposure. Full provenance at every step.
🌍
Independent Market Developer
We develop sovereign health supply infrastructure in markets where it doesn't yet exist — building the systems, relationships, and regulatory frameworks from the ground up.
AI-Powered Operations
Our Sovereign Platform uses AI to match clinical specifications against 300+ catalogues in real time — delivering compliant supply responses in hours, not months.
🛡
Full Compliance Architecture
FCPA, UK Bribery Act, OFAC, FATF, and WHO GDP compliant across all markets. KYC/AML, anti-bribery, and institutional-grade due diligence embedded at every level.
0
Active Operating Markets
Africa · Middle East
0+
Manufacturing Relationships
Direct · Approved · Active
0%
AI Clinical Match Accuracy
Specification to supply · Hours not months
Zero
Intermediaries
Principal direct only
$2.07M
Uganda Pilot Value
Completed · MOH direct
02
How It Works

One Entry.
Entire
Network.

A single procurement engagement with CSP unlocks automated access to the full manufacturing network simultaneously. Health ministries, procurement authorities, and institutional buyers don't navigate 300 relationships. They navigate one.

We carry the operational expertise, the clinical knowledge, and the direct manufacturer authority. They receive the right product, at the right specification, at the right time.

01 📋
Clinical Requirement Received
Ministry, procurement authority, or institution submits a clinical need — tender, RFP, direct order, or standing requirement.
Entry
02 🤖
AI Specification Engine
Sovereign Platform parses clinical requirements, regulatory constraints, delivery parameters, and budget envelope in real time.
Auto
03
300+ Network Activated
Every approved manufacturer relationship activated simultaneously. Best-match products identified at 93% accuracy — in hours.
Mass Exposure
04
Validated Supply Response
Compliant bid assembled with full documentation: spec, pricing, certs, regulatory approvals, delivery schedule, and KYC/AML pack.
Real-Time
05 🏥
Clinical Supply Delivered
Right specification. Verified provenance. On time. Direct from issuing authority to last mile — with full audit trail.
Lives Saved
03
The Sovereign Platform

Intelligence at
Institutional Scale.

CSP's Sovereign Platform is not a marketplace. It is a purpose-built operational intelligence system — fusing AI, clinical knowledge, and direct manufacturer authority into a unified deployment architecture.

LAYER 01
🛡
Sovereign Data Mesh
In-country data residency. Immutable audit ledger. Ministry-grade security with FIPS 140-2 compliance and real-time replication across all nodes. National health data never leaves its borders.
In-country data residency FIPS 140-2 encrypted Immutable audit trail Ministry node replication
LAYER 02
AI Clinical Engine
Automated technical matching at 93% accuracy. Clinical specifications mapped to 300+ manufacturer catalogues in real time. Zero information drift. Zero human error. Specification to supply in hours.
93% match accuracy Spec to supply in hours 300+ catalogues live Zero information drift
LAYER 03
🌐
Global EDI Gateway
Direct electronic data interchange with 300+ approved manufacturers. From production lot to last-mile delivery — full provenance at every step. No intermediaries. No grey market. Ever.
300+ direct connections Zero intermediaries Full provenance chain Production to last mile
Single Entry.
Mass Exposure.
Real-Time.

One integration with the CSP Sovereign Platform unlocks access to the full breadth of our manufacturing network — across every approved product category, every compliant regulatory jurisdiction, and every active market we serve.

Health ministries, procurement authorities, and institutional buyers don't navigate 300 relationships. They navigate one: CSP.

04
Global Reach

22 Markets.
One Platform.

From the clinics of East Africa to the hospitals of the Gulf, CSP operates a unified sovereign infrastructure that eliminates supply chain fragmentation across the world's highest-need health economies.

Active operations across Africa and the Middle East, with accelerated expansion underway across additional markets in 2026.

🌍
12
East & Central Africa
KenyaUgandaTanzania ZambiaRwandaEthiopia DRCMozambiqueMalawi ZimbabweBurundiSouth Sudan
🌍
6
West Africa
NigeriaGhanaSenegal Côte d'IvoireCameroonSierra Leone
🌏
4
Middle East & Gulf
UAESaudi Arabia QatarKuwait
0+
Health Manufacturing
Relationships
05
Manufacturing Network

The Deepest
Approved Network
in Our Markets.

Every relationship is direct, approved, and active. No brokers. No grey market. No compromised provenance. CSP maintains principal buyer status across the world's leading health manufacturers.

Injection & Infusion Devices
48
Respiratory & Anaesthesia
42
Surgical Instruments & Packs
38
Diagnostics & Monitoring
35
Wound Care & Infection Control
32
Pharmaceuticals & IV Solutions
28
Emergency & Trauma
22
Maternal & Newborn Health
16
06
Clinical Authority

Direct From
Issuing
Authority.

CSP does not source through distribution. We hold principal status — every product carries the full clinical authority, regulatory approval, and provenance integrity of the original issuing manufacturer.

01
Principal Buyer Across 300+ Accounts
Direct commercial relationships with manufacturers. No agents, no brokers, no grey market exposure. Approved principal in every relationship.
02
Multi-Jurisdictional Regulatory Compliance
FDA, CE Mark, ISO 13485, SAHPRA, and market-specific registrations maintained across all product categories and active markets.
03
Institutional Procurement Standards
DLA, AFRICOM, UNICEF, Global Fund, and PEPFAR approved supply pathways. WHO Good Distribution Practice across all 22 markets.
04
Full Anti-Corruption Framework
FCPA, UK Bribery Act, OFAC, and FATF compliance embedded at every commercial layer — operationalised, not just documented.

Compliance Framework

FCPA
Foreign Corrupt Practices Act compliance across all US manufacturer relationships and government procurement engagements.
UK Bribery Act
Full UK Bribery Act adherence. Anti-bribery procedures, adequate procedures documentation, and regular compliance audits.
OFAC / Sanctions
OFAC sanctions screening on all counterparties, transactions, and markets. Zero tolerance for sanctions violations.
KYC / AML
Full Know Your Customer and Anti-Money Laundering protocols per CSP-KYC-TPDD-001. FATF standards applied across all markets.
WHO GDP
World Health Organization Good Distribution Practice across all 22 active markets. Cold-chain, storage, and transport protocols maintained.
FIPS 140-2
Federal Information Processing Standard encryption across all data infrastructure. In-country data residency. Ministry-grade security.
07
Institutional Reach

Serving the
World's Largest
Buyers.

CSP's supply pathways are approved and active across every major institutional health procurement framework — from bilateral defence logistics to multilateral development finance.

Ministry of Health DLA · Defense Logistics Agency AFRICOM UNICEF Supply Division Global Fund PEPFAR USAID CHAI · Clinton Health Access Initiative African Development Bank World Bank Health Projects KEMSA · Kenya ZPPA · Zambia NDA · Uganda NAFDAC · Nigeria FDA · Ghana
$0M
Uganda Pilot Value
Our $2.07M national syringe and needle procurement for the Uganda Ministry of Health — delivered using the EasyTouch product line via MHC Medical — demonstrates CSP's ability to execute at national scale, with full compliance, zero intermediaries, and complete audit trail from manufacturer to last-mile delivery point.
Every Supply Decision Saves Lives.

The gap between a clinical specification and a delivered product is where lives are lost. CSP was built to close that gap permanently. Our platform eliminates the delays, the counterfeits, the failed tenders, and the distribution failures that define health supply chains in the markets we serve. When CSP operates, supply chains become sovereign infrastructure — not a vulnerability.

0
Markets Protected
0
Manufacturer Relationships
0
AI Match Accuracy %
0
Intermediaries
CSP Holdings International · Dubai, UAE
Build the
Infrastructure.

Partner with CSP to deploy sovereign health procurement infrastructure in your market — or engage our team to explore supply, distribution, or investment opportunities.

Headquarters
Dubai, United Arab Emirates
Operations
Africa · Middle East · USA · Europe
Full website launching shortly — enquiries@csp-international.com